View ValuationHS Hyosung Advanced Materials 향후 성장Future 기준 점검 3/6HS Hyosung Advanced Materials (는) 각각 연간 60.4% 및 4.7% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 59.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 10.6% 로 예상됩니다.핵심 정보60.4%이익 성장률59.12%EPS 성장률Chemicals 이익 성장66.1%매출 성장률4.7%향후 자기자본이익률10.65%애널리스트 커버리지Low마지막 업데이트28 May 2026최근 향후 성장 업데이트Price Target Changed • Feb 03Price target increased by 10% to ₩272,500Up from ₩247,500, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₩261,000. Stock is up 49% over the past year. The company is forecast to post earnings per share of ₩464 for next year compared to ₩11,154 last year.Price Target Changed • Oct 17Price target decreased by 18% to ₩260,000Down from ₩316,000, the current price target is an average from 3 analysts. New target price is 41% above last closing price of ₩184,900. Stock is down 29% over the past year. The company is forecast to post earnings per share of ₩11,442 for next year compared to ₩11,154 last year.Major Estimate Revision • Apr 12Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from ₩17,775 to ₩19,753. Revenue forecast steady at ₩3.42b. Net income forecast to grow 78% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩303,333. Share price was steady at ₩169,800 over the past week.Price Target Changed • Mar 01Price target decreased by 7.1% to ₩306,667Down from ₩330,000, the current price target is an average from 6 analysts. New target price is 64% above last closing price of ₩187,100. Stock is down 44% over the past year. The company is forecast to post earnings per share of ₩11,821 for next year compared to ₩7,957 last year.Major Estimate Revision • Feb 08Consensus EPS estimates fall by 18%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩3.49b to ₩3.35b. EPS estimate also fell from ₩21,233 per share to ₩17,402 per share. Net income forecast to grow 222% next year vs 55% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩325,714. Share price rose 12% to ₩197,600 over the past week.Price Target Changed • Jan 17Price target decreased by 9.2% to ₩351,429Down from ₩387,143, the current price target is an average from 7 analysts. New target price is 95% above last closing price of ₩180,400. Stock is down 48% over the past year. The company is forecast to post earnings per share of ₩12,780 for next year compared to ₩7,957 last year.모든 업데이트 보기Recent updatesReported Earnings • Mar 17Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: ₩4,843 loss per share (down from ₩11,154 profit in FY 2024). Revenue: ₩3.28t (flat on FY 2024). Net loss: ₩21.6b (down 143% from profit in FY 2024). Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 3.7% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.공시 • Mar 07HS Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 20, 2026HS Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 20, 2026, at 11:00 Tokyo Standard Time. Location: auditorium, 119, mapo-daero, mapo-gu, seoul South KoreaPrice Target Changed • Feb 03Price target increased by 10% to ₩272,500Up from ₩247,500, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₩261,000. Stock is up 49% over the past year. The company is forecast to post earnings per share of ₩464 for next year compared to ₩11,154 last year.분석 기사 • Jan 28Hs Hyosung Advanced Materials' (KRX:298050) 45% Share Price Surge Not Quite Adding UpHs Hyosung Advanced Materials ( KRX:298050 ) shares have had a really impressive month, gaining 45% after a shaky...Upcoming Dividend • Dec 22Upcoming dividend of ₩6,500 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 02 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.4%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.3%).분석 기사 • Dec 16Hs Hyosung Advanced Materials (KRX:298050) Will Pay A Dividend Of ₩6500.00Hs Hyosung Advanced Materials ( KRX:298050 ) has announced that it will pay a dividend of ₩6500.00 per share on the 2nd...분석 기사 • Nov 10Hs Hyosung Advanced Materials' (KRX:298050) Dividend Will Be ₩6500.00Hs Hyosung Advanced Materials ( KRX:298050 ) will pay a dividend of ₩6500.00 on the 2nd of April. Based on this...Declared Dividend • Nov 08Dividend of ₩6,500 announcedDividend of ₩6,500 is the same as last year. Ex-date: 29th December 2025 Payment date: 2nd April 2026 Dividend yield will be 3.4%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 12x earnings) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 46 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 1,267% to bring the payout ratio under control. EPS is expected to grow by 329% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.공시 • Nov 07Hs Hyosung Advanced Materials announces Annual dividend, payable on April 02, 2026Hs Hyosung Advanced Materials announced Annual dividend of KRW 6500.0000 per share payable on April 02, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.분석 기사 • Nov 03Pinning Down Hs Hyosung Advanced Materials' (KRX:298050) P/S Is Difficult Right NowThere wouldn't be many who think Hs Hyosung Advanced Materials' ( KRX:298050 ) price-to-sales (or "P/S") ratio of 0.2x...Price Target Changed • Oct 17Price target decreased by 18% to ₩260,000Down from ₩316,000, the current price target is an average from 3 analysts. New target price is 41% above last closing price of ₩184,900. Stock is down 29% over the past year. The company is forecast to post earnings per share of ₩11,442 for next year compared to ₩11,154 last year.분석 기사 • Jul 10These 4 Measures Indicate That Hs Hyosung Advanced Materials (KRX:298050) Is Using Debt ExtensivelyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...분석 기사 • Jun 26What Is Hs Hyosung Advanced Materials's (KRX:298050) Share Price Doing?While Hs Hyosung Advanced Materials ( KRX:298050 ) might not have the largest market cap around , it led the KOSE...Major Estimate Revision • Apr 12Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from ₩17,775 to ₩19,753. Revenue forecast steady at ₩3.42b. Net income forecast to grow 78% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩303,333. Share price was steady at ₩169,800 over the past week.분석 기사 • Apr 09Investors Appear Satisfied With Hs Hyosung Advanced Materials' (KRX:298050) ProspectsWith a price-to-earnings (or "P/E") ratio of 14.2x Hs Hyosung Advanced Materials ( KRX:298050 ) may be sending bearish...분석 기사 • Mar 20Hs Hyosung Advanced Materials' (KRX:298050) Promising Earnings May Rest On Soft FoundationsHs Hyosung Advanced Materials ( KRX:298050 ) announced strong profits, but the stock was stagnant. Our analysis...Reported Earnings • Mar 14Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: ₩11,154 (up from ₩10,057 in FY 2023). Revenue: ₩3.31t (up 3.4% from FY 2023). Net income: ₩49.8b (up 11% from FY 2023). Profit margin: 1.5% (up from 1.4% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.6%. Revenue is forecast to grow 3.9% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 49 percentage points per year, which is a significant difference in performance.Price Target Changed • Mar 01Price target decreased by 7.1% to ₩306,667Down from ₩330,000, the current price target is an average from 6 analysts. New target price is 64% above last closing price of ₩187,100. Stock is down 44% over the past year. The company is forecast to post earnings per share of ₩11,821 for next year compared to ₩7,957 last year.공시 • Feb 27Hs Hyosung Advanced Materials, Annual General Meeting, Mar 20, 2025Hs Hyosung Advanced Materials, Annual General Meeting, Mar 20, 2025, at 11:00 Tokyo Standard Time. Location: auditorium, 119, mapo-daero, mapo-gu, seoul South KoreaValuation Update With 7 Day Price Move • Feb 10Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩196,000, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total loss to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩351,582 per share.Major Estimate Revision • Feb 08Consensus EPS estimates fall by 18%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩3.49b to ₩3.35b. EPS estimate also fell from ₩21,233 per share to ₩17,402 per share. Net income forecast to grow 222% next year vs 55% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩325,714. Share price rose 12% to ₩197,600 over the past week.분석 기사 • Feb 05An Intrinsic Calculation For Hs Hyosung Advanced Materials (KRX:298050) Suggests It's 48% UndervaluedKey Insights The projected fair value for Hs Hyosung Advanced Materials is ₩379,182 based on 2 Stage Free Cash Flow to...Price Target Changed • Jan 17Price target decreased by 9.2% to ₩351,429Down from ₩387,143, the current price target is an average from 7 analysts. New target price is 95% above last closing price of ₩180,400. Stock is down 48% over the past year. The company is forecast to post earnings per share of ₩12,780 for next year compared to ₩7,957 last year.Upcoming Dividend • Dec 20Upcoming dividend of ₩6,500 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 02 April 2025. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 3.4%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%).분석 기사 • Dec 16Hs Hyosung Advanced Materials (KRX:298050) Has No Shortage Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • Nov 11Hs Hyosung Advanced Materials (KRX:298050) Stocks Pounded By 28% But Not Lagging Market On Growth Or PricingHs Hyosung Advanced Materials ( KRX:298050 ) shareholders that were waiting for something to happen have been dealt a...Price Target Changed • Nov 08Price target decreased by 8.5% to ₩431,429Down from ₩471,250, the current price target is an average from 7 analysts. New target price is 106% above last closing price of ₩209,000. Stock is down 44% over the past year. The company is forecast to post earnings per share of ₩12,816 for next year compared to ₩7,957 last year.Valuation Update With 7 Day Price Move • Nov 06Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩221,500, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total loss to shareholders of 61% over the past three years.분석 기사 • Oct 23Hs Hyosung Advanced Materials (KRX:298050) Hasn't Managed To Accelerate Its ReturnsTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Major Estimate Revision • Oct 21Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩3.38b to ₩3.35b. EPS estimate also fell from ₩23,006 per share to ₩20,646 per share. Net income forecast to grow 278% next year vs 56% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩497,500 to ₩471,250. Share price fell 4.8% to ₩260,000 over the past week.분석 기사 • Sep 05Is Hyosung Advanced Materials (KRX:298050) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩4,364 (vs ₩2,700 in 2Q 2023)Second quarter 2024 results: EPS: ₩4,364 (up from ₩2,700 in 2Q 2023). Revenue: ₩840.5b (up 3.0% from 2Q 2023). Net income: ₩19.5b (up 62% from 2Q 2023). Profit margin: 2.3% (up from 1.5% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.분석 기사 • Aug 07Revenues Not Telling The Story For Hyosung Advanced Materials Corporation (KRX:298050)With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Korea, you could be...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩273,000, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 49% over the past three years.Major Estimate Revision • Jul 30Consensus EPS estimates fall by 16%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩3.49b to ₩3.38b. EPS estimate also fell from ₩27,573 per share to ₩23,226 per share. Net income forecast to grow 412% next year vs 45% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩505,000. Share price fell 5.9% to ₩312,500 over the past week.분석 기사 • Jun 21Return Trends At Hyosung Advanced Materials (KRX:298050) Aren't AppealingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...분석 기사 • May 29Is Hyosung Advanced Materials (KRX:298050) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • May 19First quarter 2024 earnings released: EPS: ₩4,523 (vs ₩7,397 in 1Q 2023)First quarter 2024 results: EPS: ₩4,523 (down from ₩7,397 in 1Q 2023). Revenue: ₩836.8b (flat on 1Q 2023). Net income: ₩20.2b (down 39% from 1Q 2023). Profit margin: 2.4% (down from 4.0% in 1Q 2023). Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.분석 기사 • Apr 29Estimating The Intrinsic Value Of Hyosung Advanced Materials Corporation (KRX:298050)Key Insights Using the 2 Stage Free Cash Flow to Equity, Hyosung Advanced Materials fair value estimate is ₩456,591...분석 기사 • Apr 12Is Now The Time To Look At Buying Hyosung Advanced Materials Corporation (KRX:298050)?Hyosung Advanced Materials Corporation ( KRX:298050 ), is not the largest company out there, but it saw significant...Reported Earnings • Mar 09Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: ₩7,957 (down from ₩28,053 in FY 2022). Revenue: ₩3.20t (down 17% from FY 2022). Net income: ₩35.6b (down 72% from FY 2022). Profit margin: 1.1% (down from 3.3% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) also missed analyst estimates by 55%. Revenue is forecast to grow 7.3% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Major Estimate Revision • Jan 30Consensus EPS estimates fall by 36%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩3.54b to ₩3.36b. EPS estimate also fell from ₩32,794 per share to ₩20,938 per share. Net income forecast to grow 75% next year vs 73% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩522,857. Share price was steady at ₩338,000 over the past week.Upcoming Dividend • Dec 20Upcoming dividend of ₩15,000 per share at 3.9% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 04 April 2024. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.9%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).Buying Opportunity • Nov 23Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 8.8%. The fair value is estimated to be ₩494,021, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 13% in 2 years. Earnings is forecast to grow by 276% in the next 2 years.Price Target Changed • Nov 01Price target decreased by 9.9% to ₩515,000Down from ₩571,667, the current price target is an average from 6 analysts. New target price is 42% above last closing price of ₩361,500. Stock is up 12% over the past year. The company is forecast to post earnings per share of ₩14,438 for next year compared to ₩28,053 last year.Buying Opportunity • Oct 26Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be ₩440,235, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 5.7% in 2 years. Earnings is forecast to grow by 142% in the next 2 years.Major Estimate Revision • Oct 25Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩3.30b to ₩3.26b. EPS estimate also fell from ₩23,959 per share to ₩20,376 per share. Net income forecast to grow 78% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩598,333 to ₩571,667. Share price was steady at ₩355,000 over the past week.Major Estimate Revision • Oct 23Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from ₩25,211 to ₩22,413 per share. Revenue forecast steady at ₩3.29b. Net income forecast to grow 89% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩598,333 to ₩583,333. Share price fell 9.2% to ₩338,500 over the past week.Buying Opportunity • Sep 01Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 2.7%. The fair value is estimated to be ₩562,655, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 6.1% in 2 years. Earnings is forecast to grow by 168% in the next 2 years.New Risk • Aug 26New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 19% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 97% Cash payout ratio: 96% Minor Risk Profit margins are more than 30% lower than last year (2.0% net profit margin).Buying Opportunity • Aug 10Now 20% undervaluedOver the last 90 days, the stock is up 7.7%. The fair value is estimated to be ₩568,259, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 1.6% in 2 years. Earnings is forecast to grow by 73% in the next 2 years.Major Estimate Revision • Aug 02Consensus EPS estimates fall by 18%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩3.36b to ₩3.30b. EPS estimate also fell from ₩33,311 per share to ₩27,227 per share. Net income forecast to grow 31% next year vs 32% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩598,000. Share price rose 5.4% to ₩475,500 over the past week.Major Estimate Revision • Jul 13Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩3.47b to ₩3.36b. EPS estimate also fell from ₩38,283 per share to ₩33,311 per share. Net income forecast to grow 57% next year vs 34% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩587,500. Share price rose 2.0% to ₩451,000 over the past week.Price Target Changed • May 18Price target increased by 7.4% to ₩580,000Up from ₩540,000, the current price target is an average from 4 analysts. New target price is 33% above last closing price of ₩436,500. Stock is down 4.3% over the past year. The company is forecast to post earnings per share of ₩38,283 for next year compared to ₩28,053 last year.Reported Earnings • Mar 10Full year 2022 earnings released: EPS: ₩28,053 (vs ₩56,109 in FY 2021)Full year 2022 results: EPS: ₩28,053 (down from ₩56,109 in FY 2021). Revenue: ₩3.84t (up 6.8% from FY 2021). Net income: ₩125.3b (down 50% from FY 2021). Profit margin: 3.3% (down from 7.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.6% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 89% per year whereas the company’s share price has increased by 84% per year.Upcoming Dividend • Dec 21Upcoming dividend of ₩10,000 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 04 April 2023. Payout ratio is a comfortable 25% and the cash payout ratio is 83%. Trailing yield: 2.9%. Lower than top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%).Price Target Changed • Nov 16Price target decreased to ₩550,000Down from ₩648,333, the current price target is an average from 3 analysts. New target price is 39% above last closing price of ₩396,000. Stock is down 39% over the past year. The company is forecast to post earnings per share of ₩40,964 for next year compared to ₩56,109 last year.Price Target Changed • Nov 03Price target decreased to ₩587,500Down from ₩648,333, the current price target is an average from 4 analysts. New target price is 82% above last closing price of ₩323,000. Stock is down 53% over the past year. The company is forecast to post earnings per share of ₩44,900 for next year compared to ₩56,109 last year.Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩336,500, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 172% over the past three years.Price Target Changed • Sep 26Price target decreased to ₩625,000Down from ₩675,000, the current price target is an average from 6 analysts. New target price is 81% above last closing price of ₩344,500. Stock is down 57% over the past year. The company is forecast to post earnings per share of ₩44,900 for next year compared to ₩56,109 last year.Reported Earnings • Aug 15Second quarter 2022 earnings released: EPS: ₩10,197 (vs ₩16,930 in 2Q 2021)Second quarter 2022 results: EPS: ₩10,197 (down from ₩16,930 in 2Q 2021). Revenue: ₩1.02t (up 18% from 2Q 2021). Net income: ₩45.6b (down 40% from 2Q 2021). Profit margin: 4.4% (down from 8.7% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 24% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 119% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.Price Target Changed • Jul 07Price target decreased to ₩675,000Down from ₩744,800, the current price target is an average from 6 analysts. New target price is 84% above last closing price of ₩367,500. Stock is down 28% over the past year. The company is forecast to post earnings per share of ₩52,362 for next year compared to ₩56,109 last year.Reported Earnings • Mar 12Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: ₩56,109 (up from ₩18.00 in FY 2020). Revenue: ₩3.60t (up 50% from FY 2020). Net income: ₩250.7b (up ₩250.6b from FY 2020). Profit margin: 7.0% (up from 0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 8.1%. Over the next year, revenue is forecast to grow 1.7%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 111% per year but the company’s share price has only increased by 59% per year, which means it is significantly lagging earnings growth.공시 • Jan 30Hyosung Advanced Materials Corporation to Report Q4, 2021 Results on Feb 07, 2022Hyosung Advanced Materials Corporation announced that they will report Q4, 2021 results on Feb 07, 2022Major Estimate Revision • Jan 30Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩57,267 to ₩41,940. Revenue forecast unchanged from ₩3.45b at last update. Net income forecast to shrink 2.8% next year vs 36% growth forecast for Chemicals industry in South Korea . Consensus price target of ₩822,000 unchanged from last update. Share price fell 13% to ₩423,000 over the past week.Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩422,000, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 269% over the past three years.Price Target Changed • Dec 23Price target increased to ₩822,000Up from ₩744,800, the current price target is an average from 6 analysts. New target price is 29% above last closing price of ₩635,000. Stock is up 338% over the past year. The company is forecast to post earnings per share of ₩61,954 for next year compared to ₩17.60 last year.Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩716,000, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 534% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩437,449 per share.Valuation Update With 7 Day Price Move • Oct 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩717,000, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 441% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩431,222 per share.Valuation Update With 7 Day Price Move • Oct 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩717,000, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 441% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩431,222 per share.Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₩741,000, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 397% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩402,937 per share.Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩625,000, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 303% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩392,425 per share.Valuation Update With 7 Day Price Move • Jul 15Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩568,000, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 235% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩248,498 per share.Price Target Changed • May 08Price target increased to ₩508,750Up from ₩448,750, the current price target is an average from 4 analysts. New target price is 29% above last closing price of ₩393,000. Stock is up 353% over the past year.Price Target Changed • Mar 25Price target increased to ₩386,250Up from ₩331,250, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₩381,000. Stock is up 550% over the past year.분석 기사 • Mar 24Hyosung Advanced Materials (KRX:298050) Use Of Debt Could Be Considered RiskyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...공시 • Feb 27Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 18, 2021Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 18, 2021, at 09:00 Korea Standard Time.분석 기사 • Feb 26Be Wary Of Hyosung Advanced Materials (KRX:298050) And Its Returns On CapitalTo avoid investing in a business that's in decline, there's a few financial metrics that can provide early indications...Is New 90 Day High Low • Feb 17New 90-day high: ₩316,000The company is up 117% from its price of ₩145,500 on 19 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 29% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩348,944 per share.분석 기사 • Feb 11Hyosung Advanced Materials (KRX:298050) Shareholders Have Enjoyed An Impressive 202% Share Price GainUnless you borrow money to invest, the potential losses are limited. On the other hand, if you find a high quality...Price Target Changed • Jan 30Price target raised to ₩201,750Up from ₩176,750, the current price target is an average from 4 analysts. The new target price is 11% below the current share price of ₩226,500. As of last close, the stock is up 127% over the past year.공시 • Jan 28Hyosung Advanced Materials Corporation(KOSE:A298050) dropped from FTSE All-World Index (USD)Hyosung Advanced Materials Corporation(KOSE:A298050) dropped from FTSE All-World Index (USD)Is New 90 Day High Low • Jan 28New 90-day high: ₩233,500The company is up 75% from its price of ₩133,500 on 30 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 34% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩178,114 per share.분석 기사 • Jan 27Why Hyosung Advanced Materials Corporation (KRX:298050) Could Be Worth WatchingWhile Hyosung Advanced Materials Corporation ( KRX:298050 ) might not be the most widely known stock at the moment, it...분석 기사 • Jan 12Hyosung Advanced Materials Corporation's (KRX:298050) About To Shift From Loss To ProfitWith the business potentially at an important milestone, we thought we'd take a closer look at Hyosung Advanced...Is New 90 Day High Low • Jan 07New 90-day high: ₩160,000The company is up 10.0% from its price of ₩145,500 on 08 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩191,507 per share.분석 기사 • Dec 27What Is The Ownership Structure Like For Hyosung Advanced Materials Corporation (KRX:298050)?If you want to know who really controls Hyosung Advanced Materials Corporation ( KRX:298050 ), then you'll have to look...분석 기사 • Dec 10Hyosung Advanced Materials Corporation (KRX:298050) Shares Could Be 22% Below Their Intrinsic Value EstimateDoes the December share price for Hyosung Advanced Materials Corporation ( KRX:298050 ) reflect what it's really worth...분석 기사 • Nov 25Is Hyosung Advanced Materials (KRX:298050) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Is New 90 Day High Low • Oct 26New 90-day low: ₩122,500The company is down 4.0% from its price of ₩128,000 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩206,785 per share.이익 및 매출 성장 예측KOSE:A298050 - 애널리스트 향후 추정치 및 과거 재무 데이터 (KRW Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20283,739,000105,333192,500405,333312/31/20273,636,525103,175200,000397,000412/31/20263,561,43367,025151,500341,00033/31/20263,258,518-17,17414,664237,951N/A12/31/20253,283,045-21,639-15,029210,097N/A9/30/20253,302,056-6,671-7,768289,935N/A6/30/20253,330,5092,361-24,579296,675N/A3/31/20253,327,96131,699-30,773282,894N/A12/31/20243,311,22849,837-27,959328,886N/A9/30/20243,274,91732,670-434347,398N/A6/30/20243,228,78140,212-11,601334,916N/A3/31/20243,204,68432,432-82,658301,905N/A12/31/20233,202,33144,934-6,475352,903N/A9/30/20233,272,03750,10610,880315,505N/A6/30/20233,464,07168,81870,093335,552N/A3/31/20233,672,526102,318119,708351,681N/A12/31/20223,841,373125,340121,986350,446N/A9/30/20223,992,339181,077114,903339,716N/A6/30/20223,984,090234,435164,133358,410N/A3/31/20223,831,629264,520129,235289,276N/A12/31/20213,597,777250,69787,445234,660N/A9/30/20213,301,346214,72482,523220,135N/A6/30/20212,971,094147,017148,581283,055N/A3/31/20212,475,93236,299142,980319,576N/A12/31/20202,394,62379147,432312,388N/A9/30/20202,397,673-66,89114,198229,423N/A6/30/20202,525,139-131,644-91,698180,344N/A3/31/20202,940,063-87,130-117,768137,239N/A12/31/20193,053,616-69,987N/A127,017N/A9/30/20194,386,596-67,694N/A240,826N/A12/31/20183,029,979-45,364N/A155,917N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: A298050 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(3.1%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: A298050 (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: A298050 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: A298050 의 수익(연간 4.7%)이 KR 시장(연간 16.3%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: A298050 의 수익(연간 4.7%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: A298050의 자본 수익률은 3년 후 10.6%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/11 11:16종가2026/06/11 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스HS Hyosung Advanced Materials Corporation는 8명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jungwon WeeDaishin Securities Co. Ltd.Hee Cheol LeeDAOL Investment & Securities Co., Ltd.Yu-Jin JeoniM Securities5명의 분석가 더 보기
Price Target Changed • Feb 03Price target increased by 10% to ₩272,500Up from ₩247,500, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₩261,000. Stock is up 49% over the past year. The company is forecast to post earnings per share of ₩464 for next year compared to ₩11,154 last year.
Price Target Changed • Oct 17Price target decreased by 18% to ₩260,000Down from ₩316,000, the current price target is an average from 3 analysts. New target price is 41% above last closing price of ₩184,900. Stock is down 29% over the past year. The company is forecast to post earnings per share of ₩11,442 for next year compared to ₩11,154 last year.
Major Estimate Revision • Apr 12Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from ₩17,775 to ₩19,753. Revenue forecast steady at ₩3.42b. Net income forecast to grow 78% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩303,333. Share price was steady at ₩169,800 over the past week.
Price Target Changed • Mar 01Price target decreased by 7.1% to ₩306,667Down from ₩330,000, the current price target is an average from 6 analysts. New target price is 64% above last closing price of ₩187,100. Stock is down 44% over the past year. The company is forecast to post earnings per share of ₩11,821 for next year compared to ₩7,957 last year.
Major Estimate Revision • Feb 08Consensus EPS estimates fall by 18%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩3.49b to ₩3.35b. EPS estimate also fell from ₩21,233 per share to ₩17,402 per share. Net income forecast to grow 222% next year vs 55% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩325,714. Share price rose 12% to ₩197,600 over the past week.
Price Target Changed • Jan 17Price target decreased by 9.2% to ₩351,429Down from ₩387,143, the current price target is an average from 7 analysts. New target price is 95% above last closing price of ₩180,400. Stock is down 48% over the past year. The company is forecast to post earnings per share of ₩12,780 for next year compared to ₩7,957 last year.
Reported Earnings • Mar 17Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: ₩4,843 loss per share (down from ₩11,154 profit in FY 2024). Revenue: ₩3.28t (flat on FY 2024). Net loss: ₩21.6b (down 143% from profit in FY 2024). Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 3.7% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
공시 • Mar 07HS Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 20, 2026HS Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 20, 2026, at 11:00 Tokyo Standard Time. Location: auditorium, 119, mapo-daero, mapo-gu, seoul South Korea
Price Target Changed • Feb 03Price target increased by 10% to ₩272,500Up from ₩247,500, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₩261,000. Stock is up 49% over the past year. The company is forecast to post earnings per share of ₩464 for next year compared to ₩11,154 last year.
분석 기사 • Jan 28Hs Hyosung Advanced Materials' (KRX:298050) 45% Share Price Surge Not Quite Adding UpHs Hyosung Advanced Materials ( KRX:298050 ) shares have had a really impressive month, gaining 45% after a shaky...
Upcoming Dividend • Dec 22Upcoming dividend of ₩6,500 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 02 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.4%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.3%).
분석 기사 • Dec 16Hs Hyosung Advanced Materials (KRX:298050) Will Pay A Dividend Of ₩6500.00Hs Hyosung Advanced Materials ( KRX:298050 ) has announced that it will pay a dividend of ₩6500.00 per share on the 2nd...
분석 기사 • Nov 10Hs Hyosung Advanced Materials' (KRX:298050) Dividend Will Be ₩6500.00Hs Hyosung Advanced Materials ( KRX:298050 ) will pay a dividend of ₩6500.00 on the 2nd of April. Based on this...
Declared Dividend • Nov 08Dividend of ₩6,500 announcedDividend of ₩6,500 is the same as last year. Ex-date: 29th December 2025 Payment date: 2nd April 2026 Dividend yield will be 3.4%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 12x earnings) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 46 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 1,267% to bring the payout ratio under control. EPS is expected to grow by 329% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
공시 • Nov 07Hs Hyosung Advanced Materials announces Annual dividend, payable on April 02, 2026Hs Hyosung Advanced Materials announced Annual dividend of KRW 6500.0000 per share payable on April 02, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
분석 기사 • Nov 03Pinning Down Hs Hyosung Advanced Materials' (KRX:298050) P/S Is Difficult Right NowThere wouldn't be many who think Hs Hyosung Advanced Materials' ( KRX:298050 ) price-to-sales (or "P/S") ratio of 0.2x...
Price Target Changed • Oct 17Price target decreased by 18% to ₩260,000Down from ₩316,000, the current price target is an average from 3 analysts. New target price is 41% above last closing price of ₩184,900. Stock is down 29% over the past year. The company is forecast to post earnings per share of ₩11,442 for next year compared to ₩11,154 last year.
분석 기사 • Jul 10These 4 Measures Indicate That Hs Hyosung Advanced Materials (KRX:298050) Is Using Debt ExtensivelyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
분석 기사 • Jun 26What Is Hs Hyosung Advanced Materials's (KRX:298050) Share Price Doing?While Hs Hyosung Advanced Materials ( KRX:298050 ) might not have the largest market cap around , it led the KOSE...
Major Estimate Revision • Apr 12Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from ₩17,775 to ₩19,753. Revenue forecast steady at ₩3.42b. Net income forecast to grow 78% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩303,333. Share price was steady at ₩169,800 over the past week.
분석 기사 • Apr 09Investors Appear Satisfied With Hs Hyosung Advanced Materials' (KRX:298050) ProspectsWith a price-to-earnings (or "P/E") ratio of 14.2x Hs Hyosung Advanced Materials ( KRX:298050 ) may be sending bearish...
분석 기사 • Mar 20Hs Hyosung Advanced Materials' (KRX:298050) Promising Earnings May Rest On Soft FoundationsHs Hyosung Advanced Materials ( KRX:298050 ) announced strong profits, but the stock was stagnant. Our analysis...
Reported Earnings • Mar 14Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: ₩11,154 (up from ₩10,057 in FY 2023). Revenue: ₩3.31t (up 3.4% from FY 2023). Net income: ₩49.8b (up 11% from FY 2023). Profit margin: 1.5% (up from 1.4% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.6%. Revenue is forecast to grow 3.9% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 49 percentage points per year, which is a significant difference in performance.
Price Target Changed • Mar 01Price target decreased by 7.1% to ₩306,667Down from ₩330,000, the current price target is an average from 6 analysts. New target price is 64% above last closing price of ₩187,100. Stock is down 44% over the past year. The company is forecast to post earnings per share of ₩11,821 for next year compared to ₩7,957 last year.
공시 • Feb 27Hs Hyosung Advanced Materials, Annual General Meeting, Mar 20, 2025Hs Hyosung Advanced Materials, Annual General Meeting, Mar 20, 2025, at 11:00 Tokyo Standard Time. Location: auditorium, 119, mapo-daero, mapo-gu, seoul South Korea
Valuation Update With 7 Day Price Move • Feb 10Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩196,000, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total loss to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩351,582 per share.
Major Estimate Revision • Feb 08Consensus EPS estimates fall by 18%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩3.49b to ₩3.35b. EPS estimate also fell from ₩21,233 per share to ₩17,402 per share. Net income forecast to grow 222% next year vs 55% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩325,714. Share price rose 12% to ₩197,600 over the past week.
분석 기사 • Feb 05An Intrinsic Calculation For Hs Hyosung Advanced Materials (KRX:298050) Suggests It's 48% UndervaluedKey Insights The projected fair value for Hs Hyosung Advanced Materials is ₩379,182 based on 2 Stage Free Cash Flow to...
Price Target Changed • Jan 17Price target decreased by 9.2% to ₩351,429Down from ₩387,143, the current price target is an average from 7 analysts. New target price is 95% above last closing price of ₩180,400. Stock is down 48% over the past year. The company is forecast to post earnings per share of ₩12,780 for next year compared to ₩7,957 last year.
Upcoming Dividend • Dec 20Upcoming dividend of ₩6,500 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 02 April 2025. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 3.4%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%).
분석 기사 • Dec 16Hs Hyosung Advanced Materials (KRX:298050) Has No Shortage Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • Nov 11Hs Hyosung Advanced Materials (KRX:298050) Stocks Pounded By 28% But Not Lagging Market On Growth Or PricingHs Hyosung Advanced Materials ( KRX:298050 ) shareholders that were waiting for something to happen have been dealt a...
Price Target Changed • Nov 08Price target decreased by 8.5% to ₩431,429Down from ₩471,250, the current price target is an average from 7 analysts. New target price is 106% above last closing price of ₩209,000. Stock is down 44% over the past year. The company is forecast to post earnings per share of ₩12,816 for next year compared to ₩7,957 last year.
Valuation Update With 7 Day Price Move • Nov 06Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩221,500, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total loss to shareholders of 61% over the past three years.
분석 기사 • Oct 23Hs Hyosung Advanced Materials (KRX:298050) Hasn't Managed To Accelerate Its ReturnsTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Major Estimate Revision • Oct 21Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩3.38b to ₩3.35b. EPS estimate also fell from ₩23,006 per share to ₩20,646 per share. Net income forecast to grow 278% next year vs 56% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩497,500 to ₩471,250. Share price fell 4.8% to ₩260,000 over the past week.
분석 기사 • Sep 05Is Hyosung Advanced Materials (KRX:298050) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩4,364 (vs ₩2,700 in 2Q 2023)Second quarter 2024 results: EPS: ₩4,364 (up from ₩2,700 in 2Q 2023). Revenue: ₩840.5b (up 3.0% from 2Q 2023). Net income: ₩19.5b (up 62% from 2Q 2023). Profit margin: 2.3% (up from 1.5% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
분석 기사 • Aug 07Revenues Not Telling The Story For Hyosung Advanced Materials Corporation (KRX:298050)With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Korea, you could be...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩273,000, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 49% over the past three years.
Major Estimate Revision • Jul 30Consensus EPS estimates fall by 16%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩3.49b to ₩3.38b. EPS estimate also fell from ₩27,573 per share to ₩23,226 per share. Net income forecast to grow 412% next year vs 45% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩505,000. Share price fell 5.9% to ₩312,500 over the past week.
분석 기사 • Jun 21Return Trends At Hyosung Advanced Materials (KRX:298050) Aren't AppealingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
분석 기사 • May 29Is Hyosung Advanced Materials (KRX:298050) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • May 19First quarter 2024 earnings released: EPS: ₩4,523 (vs ₩7,397 in 1Q 2023)First quarter 2024 results: EPS: ₩4,523 (down from ₩7,397 in 1Q 2023). Revenue: ₩836.8b (flat on 1Q 2023). Net income: ₩20.2b (down 39% from 1Q 2023). Profit margin: 2.4% (down from 4.0% in 1Q 2023). Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
분석 기사 • Apr 29Estimating The Intrinsic Value Of Hyosung Advanced Materials Corporation (KRX:298050)Key Insights Using the 2 Stage Free Cash Flow to Equity, Hyosung Advanced Materials fair value estimate is ₩456,591...
분석 기사 • Apr 12Is Now The Time To Look At Buying Hyosung Advanced Materials Corporation (KRX:298050)?Hyosung Advanced Materials Corporation ( KRX:298050 ), is not the largest company out there, but it saw significant...
Reported Earnings • Mar 09Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: ₩7,957 (down from ₩28,053 in FY 2022). Revenue: ₩3.20t (down 17% from FY 2022). Net income: ₩35.6b (down 72% from FY 2022). Profit margin: 1.1% (down from 3.3% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) also missed analyst estimates by 55%. Revenue is forecast to grow 7.3% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Major Estimate Revision • Jan 30Consensus EPS estimates fall by 36%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩3.54b to ₩3.36b. EPS estimate also fell from ₩32,794 per share to ₩20,938 per share. Net income forecast to grow 75% next year vs 73% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩522,857. Share price was steady at ₩338,000 over the past week.
Upcoming Dividend • Dec 20Upcoming dividend of ₩15,000 per share at 3.9% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 04 April 2024. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.9%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).
Buying Opportunity • Nov 23Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 8.8%. The fair value is estimated to be ₩494,021, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 13% in 2 years. Earnings is forecast to grow by 276% in the next 2 years.
Price Target Changed • Nov 01Price target decreased by 9.9% to ₩515,000Down from ₩571,667, the current price target is an average from 6 analysts. New target price is 42% above last closing price of ₩361,500. Stock is up 12% over the past year. The company is forecast to post earnings per share of ₩14,438 for next year compared to ₩28,053 last year.
Buying Opportunity • Oct 26Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be ₩440,235, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 5.7% in 2 years. Earnings is forecast to grow by 142% in the next 2 years.
Major Estimate Revision • Oct 25Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩3.30b to ₩3.26b. EPS estimate also fell from ₩23,959 per share to ₩20,376 per share. Net income forecast to grow 78% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩598,333 to ₩571,667. Share price was steady at ₩355,000 over the past week.
Major Estimate Revision • Oct 23Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from ₩25,211 to ₩22,413 per share. Revenue forecast steady at ₩3.29b. Net income forecast to grow 89% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩598,333 to ₩583,333. Share price fell 9.2% to ₩338,500 over the past week.
Buying Opportunity • Sep 01Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 2.7%. The fair value is estimated to be ₩562,655, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 6.1% in 2 years. Earnings is forecast to grow by 168% in the next 2 years.
New Risk • Aug 26New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 19% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 97% Cash payout ratio: 96% Minor Risk Profit margins are more than 30% lower than last year (2.0% net profit margin).
Buying Opportunity • Aug 10Now 20% undervaluedOver the last 90 days, the stock is up 7.7%. The fair value is estimated to be ₩568,259, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 1.6% in 2 years. Earnings is forecast to grow by 73% in the next 2 years.
Major Estimate Revision • Aug 02Consensus EPS estimates fall by 18%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩3.36b to ₩3.30b. EPS estimate also fell from ₩33,311 per share to ₩27,227 per share. Net income forecast to grow 31% next year vs 32% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩598,000. Share price rose 5.4% to ₩475,500 over the past week.
Major Estimate Revision • Jul 13Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩3.47b to ₩3.36b. EPS estimate also fell from ₩38,283 per share to ₩33,311 per share. Net income forecast to grow 57% next year vs 34% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩587,500. Share price rose 2.0% to ₩451,000 over the past week.
Price Target Changed • May 18Price target increased by 7.4% to ₩580,000Up from ₩540,000, the current price target is an average from 4 analysts. New target price is 33% above last closing price of ₩436,500. Stock is down 4.3% over the past year. The company is forecast to post earnings per share of ₩38,283 for next year compared to ₩28,053 last year.
Reported Earnings • Mar 10Full year 2022 earnings released: EPS: ₩28,053 (vs ₩56,109 in FY 2021)Full year 2022 results: EPS: ₩28,053 (down from ₩56,109 in FY 2021). Revenue: ₩3.84t (up 6.8% from FY 2021). Net income: ₩125.3b (down 50% from FY 2021). Profit margin: 3.3% (down from 7.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.6% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 89% per year whereas the company’s share price has increased by 84% per year.
Upcoming Dividend • Dec 21Upcoming dividend of ₩10,000 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 04 April 2023. Payout ratio is a comfortable 25% and the cash payout ratio is 83%. Trailing yield: 2.9%. Lower than top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%).
Price Target Changed • Nov 16Price target decreased to ₩550,000Down from ₩648,333, the current price target is an average from 3 analysts. New target price is 39% above last closing price of ₩396,000. Stock is down 39% over the past year. The company is forecast to post earnings per share of ₩40,964 for next year compared to ₩56,109 last year.
Price Target Changed • Nov 03Price target decreased to ₩587,500Down from ₩648,333, the current price target is an average from 4 analysts. New target price is 82% above last closing price of ₩323,000. Stock is down 53% over the past year. The company is forecast to post earnings per share of ₩44,900 for next year compared to ₩56,109 last year.
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩336,500, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 172% over the past three years.
Price Target Changed • Sep 26Price target decreased to ₩625,000Down from ₩675,000, the current price target is an average from 6 analysts. New target price is 81% above last closing price of ₩344,500. Stock is down 57% over the past year. The company is forecast to post earnings per share of ₩44,900 for next year compared to ₩56,109 last year.
Reported Earnings • Aug 15Second quarter 2022 earnings released: EPS: ₩10,197 (vs ₩16,930 in 2Q 2021)Second quarter 2022 results: EPS: ₩10,197 (down from ₩16,930 in 2Q 2021). Revenue: ₩1.02t (up 18% from 2Q 2021). Net income: ₩45.6b (down 40% from 2Q 2021). Profit margin: 4.4% (down from 8.7% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 24% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 119% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Jul 07Price target decreased to ₩675,000Down from ₩744,800, the current price target is an average from 6 analysts. New target price is 84% above last closing price of ₩367,500. Stock is down 28% over the past year. The company is forecast to post earnings per share of ₩52,362 for next year compared to ₩56,109 last year.
Reported Earnings • Mar 12Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: ₩56,109 (up from ₩18.00 in FY 2020). Revenue: ₩3.60t (up 50% from FY 2020). Net income: ₩250.7b (up ₩250.6b from FY 2020). Profit margin: 7.0% (up from 0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 8.1%. Over the next year, revenue is forecast to grow 1.7%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 111% per year but the company’s share price has only increased by 59% per year, which means it is significantly lagging earnings growth.
공시 • Jan 30Hyosung Advanced Materials Corporation to Report Q4, 2021 Results on Feb 07, 2022Hyosung Advanced Materials Corporation announced that they will report Q4, 2021 results on Feb 07, 2022
Major Estimate Revision • Jan 30Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩57,267 to ₩41,940. Revenue forecast unchanged from ₩3.45b at last update. Net income forecast to shrink 2.8% next year vs 36% growth forecast for Chemicals industry in South Korea . Consensus price target of ₩822,000 unchanged from last update. Share price fell 13% to ₩423,000 over the past week.
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩422,000, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 269% over the past three years.
Price Target Changed • Dec 23Price target increased to ₩822,000Up from ₩744,800, the current price target is an average from 6 analysts. New target price is 29% above last closing price of ₩635,000. Stock is up 338% over the past year. The company is forecast to post earnings per share of ₩61,954 for next year compared to ₩17.60 last year.
Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩716,000, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 534% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩437,449 per share.
Valuation Update With 7 Day Price Move • Oct 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩717,000, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 441% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩431,222 per share.
Valuation Update With 7 Day Price Move • Oct 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩717,000, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 441% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩431,222 per share.
Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₩741,000, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 397% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩402,937 per share.
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩625,000, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 303% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩392,425 per share.
Valuation Update With 7 Day Price Move • Jul 15Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩568,000, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 235% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩248,498 per share.
Price Target Changed • May 08Price target increased to ₩508,750Up from ₩448,750, the current price target is an average from 4 analysts. New target price is 29% above last closing price of ₩393,000. Stock is up 353% over the past year.
Price Target Changed • Mar 25Price target increased to ₩386,250Up from ₩331,250, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₩381,000. Stock is up 550% over the past year.
분석 기사 • Mar 24Hyosung Advanced Materials (KRX:298050) Use Of Debt Could Be Considered RiskyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
공시 • Feb 27Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 18, 2021Hyosung Advanced Materials Corporation, Annual General Meeting, Mar 18, 2021, at 09:00 Korea Standard Time.
분석 기사 • Feb 26Be Wary Of Hyosung Advanced Materials (KRX:298050) And Its Returns On CapitalTo avoid investing in a business that's in decline, there's a few financial metrics that can provide early indications...
Is New 90 Day High Low • Feb 17New 90-day high: ₩316,000The company is up 117% from its price of ₩145,500 on 19 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 29% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩348,944 per share.
분석 기사 • Feb 11Hyosung Advanced Materials (KRX:298050) Shareholders Have Enjoyed An Impressive 202% Share Price GainUnless you borrow money to invest, the potential losses are limited. On the other hand, if you find a high quality...
Price Target Changed • Jan 30Price target raised to ₩201,750Up from ₩176,750, the current price target is an average from 4 analysts. The new target price is 11% below the current share price of ₩226,500. As of last close, the stock is up 127% over the past year.
공시 • Jan 28Hyosung Advanced Materials Corporation(KOSE:A298050) dropped from FTSE All-World Index (USD)Hyosung Advanced Materials Corporation(KOSE:A298050) dropped from FTSE All-World Index (USD)
Is New 90 Day High Low • Jan 28New 90-day high: ₩233,500The company is up 75% from its price of ₩133,500 on 30 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 34% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩178,114 per share.
분석 기사 • Jan 27Why Hyosung Advanced Materials Corporation (KRX:298050) Could Be Worth WatchingWhile Hyosung Advanced Materials Corporation ( KRX:298050 ) might not be the most widely known stock at the moment, it...
분석 기사 • Jan 12Hyosung Advanced Materials Corporation's (KRX:298050) About To Shift From Loss To ProfitWith the business potentially at an important milestone, we thought we'd take a closer look at Hyosung Advanced...
Is New 90 Day High Low • Jan 07New 90-day high: ₩160,000The company is up 10.0% from its price of ₩145,500 on 08 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩191,507 per share.
분석 기사 • Dec 27What Is The Ownership Structure Like For Hyosung Advanced Materials Corporation (KRX:298050)?If you want to know who really controls Hyosung Advanced Materials Corporation ( KRX:298050 ), then you'll have to look...
분석 기사 • Dec 10Hyosung Advanced Materials Corporation (KRX:298050) Shares Could Be 22% Below Their Intrinsic Value EstimateDoes the December share price for Hyosung Advanced Materials Corporation ( KRX:298050 ) reflect what it's really worth...
분석 기사 • Nov 25Is Hyosung Advanced Materials (KRX:298050) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Is New 90 Day High Low • Oct 26New 90-day low: ₩122,500The company is down 4.0% from its price of ₩128,000 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩206,785 per share.